TuisNTRA • NASDAQ
add
Natera Inc
Vorige sluiting
$201,90
Dagwisseling
$206,36 - $215,00
Jaarwisseling
$131,81 - $256,36
Markkapitalisasie
30,42 mjd USD
Gemiddelde volume
1,28 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 665,50 m | 39,79% |
Bedryfskoste | 468,21 m | 28,50% |
Netto inkomste | 47,26 m | 187,89% |
Netto winsgrens | 7,10 | 162,89% |
Wins per aandeel | 0,36 | 187,80% |
EBITDA | -13,69 m | 77,35% |
Effektiewe belastingkoers | 454,63% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 1,08 mjd | 11,14% |
Totale bates | 2,40 mjd | 44,41% |
Totale aanspreeklikheid | 685,93 m | 47,41% |
Totale ekwiteit | 1,71 mjd | — |
Uitstaande aandele | 141,73 m | — |
Prys om te bespreek | 16,47 | — |
Opbrengs op bates | -2,70% | — |
Opbrengs op kapitaal | -3,37% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 47,26 m | 187,89% |
Kontant van bedrywe | 73,89 m | 39,71% |
Kontant van beleggings | -71,59 m | -543,93% |
Kontant van finansiering | 32,41 m | 195,30% |
Netto kontantverandering | 34,70 m | -34,21% |
Beskikbare kontantvloei | 16,99 m | -69,31% |
Meer oor
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Gestig
01 Jan. 2004
Hoofkwartier
Webwerf
Werknemers
6 138
